-
February 2, 2012
Smoking tied to higher psoriasis risk
NEW YORK (Reuters Health) - Adding to the list of possible health consequences from smoking, a large study suggests that smokers have an increased risk of developing the chronic skin condition psoriasis.
-
January 10, 2012
Heart disease more likely in people with psoriasis
NEW YORK (Reuters Health) - People who suffer from psoriasis may want to pay extra attention to heart risks, according to a new study that found they are at a greater risk for blocked arteries than those who don't have the skin disease.
-
August 23, 2011
No major heart risk seen in new psoriasis drugs
CHICAGO (Reuters) - A new, highly effective class of psoriasis drugs did not appear to raise the risk of heart problems in a review of published studies, but the analysis may not have been big enough to detect rare cases, U.S. researchers said.
-
October 11, 2010
Abbott psoriasis drug succeeds in pivotal trial
NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with a commonly used medicine in a pivotal late-stage clinical trial, the company said on Monday.
-
August 17, 2010
Vitamin D not behind UVB's psoriasis benefit
NEW YORK (Reuters Health) - Ultraviolet light therapy lessens the symptoms of psoriasis and simultaneously raises vitamin D levels, a new study shows. However, increased vitamin D is probably unrelated to light therapy's benefits for psoriasis, the researchers say.
-
August 16, 2010
Psoriasis tied to depression, suicide
NEW YORK (Reuters Health) - People with the skin condition psoriasis are more likely to be depressed, anxious and thinking about suicide, than those without the problem, according to a new study of British adults.
-
January 18, 2010
Severe form of psoriasis ups heart disease risk
NEW YORK (Reuters Health) - People with severe forms of the inflammatory skin disease psoriasis are more likely to die of heart-related causes and stroke than those without the condition, new research shows.
-
November 5, 2009
Psoriatic arthritis common in people with psoriasis
NEW YORK (Reuters Health) - As many as 14 percent of people with psoriasis may also have psoriatic arthritis, research shows.
-
July 16, 2009
Psoriasis treatment may up cancer risk
NEW YORK (Reuters Health) - Patients with moderate to severe psoriasis may need life-long treatment with a variety of therapies to relieve symptoms of the scaly skin condition and research has shown that both traditional and newer therapies for psoriasis can increase patients' risk of certain cancers.
-
June 16, 2009
Psoriasis linked to strokes and death
NEW YORK (Reuters Health) - People with psoriasis, a common scaly skin condition, are at increased risk for strokes, heart disease, and circulatory problems in the legs, new research shows.
-
April 20, 2009
Psoriasis linked to diabetes, hypertension
CHICAGO (Reuters) - Women with psoriasis run a higher risk of diabetes and high blood pressure, perhaps because of the underlying inflammation that causes the skin condition, researchers said on Monday.
-
April 9, 2009
Genentech withdraws psoriasis drug from US market
LOS ANGELES (Reuters) - Genentech Inc. announced Wednesday a phased voluntary withdrawal of psoriasis drug Raptiva from the U.S. market due to its link to a brain infection.
-
November 26, 2008
Indigo extract effective treatment for psoriasis
NEW YORK (Reuters Health) - Taiwanese investigators report that an ointment made from an extract of Indigo naturalis is effective in treatment-resistant plaque psoriasis -- and the treatment appears to be safe.
-
June 18, 2008
FDA panel backs proposed J&J psoriasis drug
SILVER SPRING, Maryland (Reuters) - Johnson & Johnson's experimental drug ustekinumab should be approved for treating adults with moderate or severe psoriasis, a U.S. advisory panel unanimously ruled on Tuesday.
-
May 1, 2008
Immune drug useful for scalp psoriasis
NEW YORK (Reuters Health) - Alefacept, a drug that reduces the activity of certain immune cells, is effective in treating psoriasis of the scalp, according to a report in the Journal of the American Academy of Dermatology.
-
April 18, 2008
New immune drug safely treats psoriasis: study
WASHINGTON (Reuters) - An experimental new drug that suppresses certain parts of the immune system worked safely to relieve some of the symptoms of psoriasis, researchers in Canada reported on Thursday.
-
March 26, 2008
Diabetes drugs may prevent psoriasis
NEW YORK (Reuters Health) - The use of "thiazolidinediones" type diabetes drugs, such as Avandia and Actos, may reduce the risk of developing the scaly skin condition psoriasis, according to Swiss and US researchers.
-
February 6, 2008
Psoriasis drug may provide lasting relief: study
NEW YORK (Reuters Health) - The drug alefacept, which in 2003 was the first "biologic" agent approved in the US for the treatment of moderate to severe chronic plaque psoriasis, appears to be a long-term option for certain patients, results of a study suggests.
-
December 17, 2007
Some psoriasis linked to higher death rates: study
CHICAGO (Reuters) - People who suffer from severe psoriasis die younger than people with mild cases or without the disease, for reasons that are unclear, researchers said on Monday.
-
November 6, 2007
Smoking may raise psoriasis risk
NEW YORK (Reuters Health) - Pointing to yet another health consequence of smoking, a new study suggests that the habit raises the risk of the skin disease psoriasis.
-
October 8, 2007
Psoriasis patients' adjust to adverse reactions
BUENOS AIRES (Reuters Health) - Psoriasis patients learn to cope when others show disgust in response to their skin lesions by automatically shutting off a specific part of their brains, UK researchers report.
-
October 4, 2007
New psoriasis drug is safe and effective
BUENOS AIRES (Reuters Health) - A new psoriasis drug, which could be self-injected every 3 months, had "impressive" safety and efficacy results in a late-stage, multicenter clinical trial involving more than 1,200 patients with chronic plaque psoriasis, researchers announced here at the World Congress of Dermatology.
-
October 3, 2007
Psoriasis drug shown highly effective in trial
NEW YORK (Reuters) - Johnson & Johnson's experimental treatment for psoriasis proved safe and highly effective in a late-stage trial, positioning it as a potential strong rival to current medicines, the company said on Wednesday.
-
October 1, 2007
Abbott drug maintains psoriasis relief in trial
NEW YORK (Reuters) - A high percentage of patients taking Abbott Laboratories Inc's experimental psoriasis drug, ABT-874, maintained an impressive improvement in symptoms 12 weeks after discontinuing the treatment, the drugmaker said on Monday.
-
August 23, 2007
Being overweight may raise women's psoriasis risk
NEW YORK (Reuters Health) - Women who are overweight or obese may face a higher risk of developing the psoriasis, a common skin condition, a large study suggests.
-
July 10, 2007
Arthritis drug may treat stubborn psoriasis
NEW YORK (Reuters Health) - Patients with severe psoriasis previously treated with Enbrel (also known as etanercept) may respond to Remicade (also known as infliximab), a study published this month suggests.
-
June 18, 2007
Enbrel works well for psoriasis over long term
NEW YORK (Reuters Health) - The symptoms of moderate-to-severe psoriasis are improved by treatment with Enbrel, known generically as etanercept, and the therapy remains safe and effective for up to 96 weeks, according to a new study